Bard Associates Inc Neuroone Medical Technologies Corp Transaction History
Bard Associates Inc
- $266 Million
- Q2 2025
A detailed history of Bard Associates Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Bard Associates Inc holds 1,854,600 shares of NMTC stock, worth $1.39 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
1,854,600Holding current value
$1.39 Million% of portfolio
0.47%Shares
1 transactions
Others Institutions Holding NMTC
# of Institutions
24Shares Held
5.29MCall Options Held
69.6KPut Options Held
2K-
Perkins Capital Management Inc1.5MShares$1.13 Million1.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$833,0170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA349KShares$261,6180.0% of portfolio
-
Goldman Sachs Group Inc New York, NY98.6KShares$73,9290.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.81KShares$60,7500.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $12.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...